KELLEY SCOTT: Open Payments
NPI 1396116109 · TORONTO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,627 in 99 payments from 25 companies in 2025. Trend: 2023 $1,023 · 2024 $1,547 · 2025 $1,627
Food & beverage: $1,627
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $308 |
| Axsome Therapeutics, Inc. | 10 | $175 |
| PFIZER INC. | 11 | $150 |
| Viatris Specialty LLC | 6 | $122 |
| Novo Nordisk Inc | 5 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Amgen Inc. | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 2 | $52 |
| GlaxoSmithKline, LLC. | 3 | $50 |
Products named: VRAYLAR, Auvelity, YUPELRI, REXULTI, NURTEC ODT, CAPLYTA, ELIQUIS, QULIPTA.
Industry payments across OH — which companies pay providers there.
